These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22920012)

  • 1. Eye drops preservative as the cause of corneal band keratopathy in long-term pilocarpine hydrochloride treatment.
    Pavicić-Astalos J; Lacmanović-Loncar V; Petric-Vicković I; Sarić D; Mandić Z; Csik T; Susić N
    Acta Clin Croat; 2012 Mar; 51(1):107-11. PubMed ID: 22920012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical band keratopathy following long-term pilocarpine treatment.
    Brazier DJ; Hitchings RA
    Br J Ophthalmol; 1989 Apr; 73(4):294-6. PubMed ID: 2713309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical tolerance of antiglaucoma eyedrops with and without a preservative. Results of an unpublished survey in Europe].
    Levrat F; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 1999 Mar; 22(2):186-91. PubMed ID: 10327349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical pathologic study of mercurialentis medicamentosus.
    Garron LK; Wood IS; Spencer WH; Hayes TL
    Trans Am Ophthalmol Soc; 1976; 74():295-320. PubMed ID: 867632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritiform Keratopathy Associated with Exposure to Polyquarternium-1, a Common Ophthalmic Preservative.
    Matoba AY; Peterson JR; Wilhelmus KR
    Ophthalmology; 2016 Mar; 123(3):451-6. PubMed ID: 26686962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
    Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
    Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy.
    Yamada N; Matsuda R; Morishige N; Yanai R; Chikama TI; Nishida T; Ishimitsu T; Kamiya A
    Br J Ophthalmol; 2008 Jul; 92(7):896-900. PubMed ID: 18511539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the fellow eye in acute angle-closure glaucoma: a case report and survey of members of the American Glaucoma Society.
    Davidorf JM; Baker ND; Derick R
    J Glaucoma; 1996 Aug; 5(4):228-32. PubMed ID: 8795765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Functional outcomes after penetrating keratoplasty in pseudoexfoliation syndrome (PEX)-keratopathy].
    Nguyen NX; Lattermann V; Schlötzer-Schrehardt U; Seitz B
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):819-24. PubMed ID: 15499516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of band keratopathy with excimer phototherapeutic keratectomy: visual, refractive, and symptomatic outcome.
    Stewart OG; Morrell AJ
    Eye (Lond); 2003 Mar; 17(2):233-7. PubMed ID: 12640412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of failure in glaucoma filtering surgery: a consequence of antiglaucomatous drugs?
    Baudouin C
    Int J Clin Pharmacol Res; 1996; 16(1):29-41. PubMed ID: 9001927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further observations on atypical band keratopathy in glaucoma patients.
    Kennedy RE; Roca PD; Platt DS
    Trans Am Ophthalmol Soc; 1974; 72():107-22. PubMed ID: 4142661
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluating eye drop instillation technique in glaucoma patients.
    Gupta R; Patil B; Shah BM; Bali SJ; Mishra SK; Dada T
    J Glaucoma; 2012 Mar; 21(3):189-92. PubMed ID: 21336146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal staining after treatment with topical tetracycline.
    Lapid-Gortzak R; Nieuwendaal CP; Slomovic AR; Spanjaard L
    Cornea; 2006 Sep; 25(8):969-70. PubMed ID: 17102677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDTA chelation for calcific band keratopathy: results and long-term follow-up.
    Najjar DM; Cohen EJ; Rapuano CJ; Laibson PR
    Am J Ophthalmol; 2004 Jun; 137(6):1056-64. PubMed ID: 15183790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of intermittent angle closure glaucoma with Nd: YAG laser iridotomy as a primary procedure.
    Ahmed M
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):764-7. PubMed ID: 17125635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of band keratopathy with EDTA (author's transl)].
    Scherz W; Vogel M
    Klin Monbl Augenheilkd; 1978 Mar; 172(3):371-8. PubMed ID: 416288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic photokeratectomy for the treatment of band keratopathy].
    Dighiero P; Boudraa R; Ellies P; Saragoussi JJ; Legeais JM; Renard G
    J Fr Ophtalmol; 2000 Apr; 23(4):345-9. PubMed ID: 10794982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.